These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36136544)

  • 41. An interactive database for the investigation of high-density peptide microarray guided interaction patterns and antivenom cross-reactivity.
    Krause KE; Jenkins TP; Skaarup C; Engmark M; Casewell NR; Ainsworth S; Lomonte B; Fernández J; Gutiérrez JM; Lund O; Laustsen AH
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008366. PubMed ID: 32579606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of venom diversity and antivenom quality from the venom of long-term captive vs recently wild captured Pseudocerastes persicus snake: An In vitro and In vivo study.
    Bahmani K; Abdollahnia A; Vatanpour H; Ghassempour A; Kaboli M; Shahidi MR
    Toxicon; 2024 Apr; 241():107662. PubMed ID: 38417708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Snake antivenom: Challenges and alternate approaches.
    Alangode A; Rajan K; Nair BG
    Biochem Pharmacol; 2020 Nov; 181():114135. PubMed ID: 32628928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy of two antivenoms against the venom of North American snakes.
    Sánchez EE; Galán JA; Perez JC; Rodríguez-Acosta A; Chase PB; Pérez JC
    Toxicon; 2003 Mar; 41(3):357-65. PubMed ID: 12565759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study on the ability of IgG and F(ab')2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom.
    León G; Stiles B; Alape A; Rojas G; Gutiérrez JM
    Am J Trop Med Hyg; 1999 Aug; 61(2):266-71. PubMed ID: 10463678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variability in antivenom neutralization of Mexican viperid snake venoms.
    Guadarrama-Martínez A; Neri-Castro E; Boyer L; Alagón A
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012152. PubMed ID: 38717980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics.
    Calvete JJ; Arias AS; Rodríguez Y; Quesada-Bernat S; Sánchez LV; Chippaux JP; Pla D; Gutiérrez JM
    Toxicon; 2016 Sep; 119():280-8. PubMed ID: 27377229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Remarkable intrapopulation venom variability in the monocellate cobra (Naja kaouthia) unveils neglected aspects of India's snakebite problem.
    Rashmi U; Khochare S; Attarde S; Laxme RRS; Suranse V; Martin G; Sunagar K
    J Proteomics; 2021 Jun; 242():104256. PubMed ID: 33957314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
    Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The concept of Big Four: Road map from snakebite epidemiology to antivenom efficacy.
    Gopal G; Muralidar S; Prakash D; Kamalakkannan A; Indhuprakash ST; Thirumalai D; Ambi SV
    Int J Biol Macromol; 2023 Jul; 242(Pt 1):124771. PubMed ID: 37169043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Bitis spp. and Echis spp. African snakes.
    Gómez A; Sánchez A; Durán G; Cordero D; Segura Á; Vargas M; Solano D; Herrera M; Chaves-Araya S; Villalta M; Sánchez M; Arguedas M; Díaz C; Gutiérrez JM; León G
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010643. PubMed ID: 35960772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pan-American Lancehead Pit-Vipers: Coagulotoxic Venom Effects and Antivenom Neutralisation of
    Bourke LA; Zdenek CN; Neri-Castro E; Bénard-Valle M; Alagón A; Gutiérrez JM; Sanchez EF; Aldridge M; Fry BG
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33499001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antivenom preclinical efficacy testing against Asian snakes and their availability in Asia: A systematic review.
    Soopairin S; Patikorn C; Taychakhoonavudh S
    PLoS One; 2023; 18(7):e0288723. PubMed ID: 37467278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neutralization of two North American coral snake venoms with United States and Mexican antivenoms.
    Sánchez EE; Lopez-Johnston JC; Rodríguez-Acosta A; Pérez JC
    Toxicon; 2008 Feb; 51(2):297-303. PubMed ID: 18054059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Guidelines for the production, control and regulation of snake antivenom immunoglobulins].
    Chippaux JP
    Biol Aujourdhui; 2010; 204(1):87-91. PubMed ID: 20950580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of phylogeny, venom composition and neutralization by antivenom in diverse species of bothrops complex.
    Sousa LF; Nicolau CA; Peixoto PS; Bernardoni JL; Oliveira SS; Portes-Junior JA; Mourão RH; Lima-dos-Santos I; Sano-Martins IS; Chalkidis HM; Valente RH; Moura-da-Silva AM
    PLoS Negl Trop Dis; 2013; 7(9):e2442. PubMed ID: 24069493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Snake antivenom production in Ecuador: Poor implementation, and an unplanned cessation leads to a call for a renaissance.
    Ortiz-Prado E; Yeager J; Andrade F; Schiavi-Guzman C; Abedrabbo-Figueroa P; Terán E; Gómez-Barreno L; Simbaña-Rivera K; Izquierdo-Condoy JS
    Toxicon; 2021 Oct; 202():90-97. PubMed ID: 34571098
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop.
    Gutiérrez JM; Fan HW; Silvera CL; Angulo Y
    Toxicon; 2009 May; 53(6):625-30. PubMed ID: 19673076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the effect of Crotalus simus and Crotalus durissus ruruima venoms on the equine antibody response towards Bothrops asper venom: implications for the production of polyspecific snake antivenoms.
    Dos-Santos MC; Arroyo C; Solano S; Herrera M; Villalta M; Segura A; Estrada R; Gutiérrez JM; León G
    Toxicon; 2011 Feb; 57(2):237-43. PubMed ID: 21130107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perspective on the Therapeutics of Anti-Snake Venom.
    Gómez-Betancur I; Gogineni V; Salazar-Ospina A; León F
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31505752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.